Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Schizophrenia Research
|
May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance
T Rasmussen, A Fink-Jensen, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic
M D Swedberg, M J Sheardown, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)
F P Bymaster, D T Wong, C H Mitch, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors
H E Shannon, F P Bymaster, D O Calligaro, et al.
European Journal of Pharmacology
|
October 17, 1998
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane
F P Bymaster, H E Shannon, K Rasmussen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation
P Sauerberg, L Jeppesen, P H Olesen, et al.
European Journal of Pharmacology
|
August 26, 2000
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice
T Rasmussen, P Sauerberg, E B Nielsen, et al.
Journal of Medicinal Chemistry
|
September 1, 1995
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles
J S Ward, L Merritt, D O Calligaro, et al.
Journal of Medicinal Chemistry
|
October 23, 1998
Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity
P Sauerberg, L Jeppesen, P H Olesen, et al.
Life Sciences
|
March 9, 1999
Potential role of muscarinic receptors in schizophrenia
F P Bymaster, H E Shannon, K Rasmussen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Schizophrenia Research
|
May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance
T Rasmussen, A Fink-Jensen, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic
M D Swedberg, M J Sheardown, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)
F P Bymaster, D T Wong, C H Mitch, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1994
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors
H E Shannon, F P Bymaster, D O Calligaro, et al.
European Journal of Pharmacology
|
October 17, 1998
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane
F P Bymaster, H E Shannon, K Rasmussen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation
P Sauerberg, L Jeppesen, P H Olesen, et al.
European Journal of Pharmacology
|
August 26, 2000
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice
T Rasmussen, P Sauerberg, E B Nielsen, et al.
Journal of Medicinal Chemistry
|
September 1, 1995
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles
J S Ward, L Merritt, D O Calligaro, et al.
Journal of Medicinal Chemistry
|
October 23, 1998
Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity
P Sauerberg, L Jeppesen, P H Olesen, et al.
Life Sciences
|
March 9, 1999
Potential role of muscarinic receptors in schizophrenia
F P Bymaster, H E Shannon, K Rasmussen, et al.
Page
of 6